A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma
Clinical trial NCT01801436 · COMPLETED
Trial details
- NCT number
- NCT01801436
- Sponsor
- Johnson & Johnson Taiwan Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.